Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Published in: Journal of Thrombosis and Thrombolysis 2/2006

01-04-2006 | Basic Investigation and Translational Science

Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?

Authors: Antonio Tello-Montoliu, Vanessa Roldán, Vicente E Climent, Francisco Sogorb, Gregory YH Lip, Francisco Marín

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2006

Login to get access
Metadata
Title
Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?
Authors
Antonio Tello-Montoliu
Vanessa Roldán
Vicente E Climent
Francisco Sogorb
Gregory YH Lip
Francisco Marín
Publication date
01-04-2006
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2006
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-006-4384-4

Other articles of this Issue 2/2006

Journal of Thrombosis and Thrombolysis 2/2006 Go to the issue

Case Reports and Reviews

Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients

Case Reports and Reviews

Massive pulmonary embolism in a Lebanese patient doubly heterozygous for MTHFR and Factor V Leiden presenting with syncope and treated with tenecteplase

Clinical Trials

The use of a HEMOCHRON® JR. HEMONOX™ point of care test in monitoring the anticoagulant effects of enoxaparin during interventional coronary procedures

Laboratory Medicine

Association between plasma levels of D-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders

Case Reports and Reviews

Arterial and venous thrombosis in patients with von Willebrand’s disease: A critical review of the literature

Clinical Trials

Doppler ultrasonography versus venography in the detection of deep vein thrombosis in patients with pulmonary embolism
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits